We understand that the anticipation of your first visit can be filled with anxiety. You are about to meet a team of medical professionals dedicated to your recovery.
By David Sampson A new study revisits an analysis made by the same lab in 2015 about the role of random mutations on cancer. The analysis uses computer modeling to estimate how many cancers are the result of replication errors. … Read More
By David Sampson A groundbreaking study by American Cancer Society epidemiologist Rebecca Siegel, MPH finds that people born in the United States in 1990 have double the risk of colon cancer and quadruple the risk of rectal cancer compared to … Read More
The Detroit Research on Cancer Survivors (ROCS) study, which will include 5,560 cancer survivors, will look at the major factors affecting cancer progression, recurrence, mortality, and quality of life among African-American cancer survivors. …read more Source:: Cancer
Premature death rates declined among Hispanics, blacks, and Asian/Pacific Islanders due mainly to fewer deaths from cancer, heart disease, and HIV. Rising deaths from accidents, drug overdoses, suicide and liver disease increased rates among whites and American Indian/Alaska Natives. …read … Read More
By David Sampson A new study corrects cervical cancer incidence and mortality rates to account for hysterectomy, and finds both incidence and mortality of cervical cancer has been grossly underestimated, especially in the black population, in which hysterectomy rates are … Read More
Investigators with The Cancer Genome Atlas (TCGA) Research Network have identified novel genomic and molecular characteristics of cervical cancer that will aid in subclassification of the disease and may help target therapies that are most appropriate for each patient. …read … Read More
The National Cancer Institute (NCI) today launched a new drug formulary (the “NCI Formulary”) that will enable investigators at NCI-designated Cancer Centers to have quicker access to approved and investigational agents for use in preclinical studies and cancer clinical trials. … Read More
In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the peripheral nerves, tolerated selumetinib and, in most cases, responded to it with tumor … Read More
By David Sampson As the holidays approach and the year ends, a lot of people are looking for ways to give back, whether it’s gifts to loved ones or donations to their favorite charity (and of course we hope you’ll … Read More
In a study of an immune therapy for colorectal cancer that involved a single patient, researchers identified a method for targeting the cancer-causing protein produced by a mutant form of the KRAS gene. …read more Source:: Cancer
6827 W Tropicana Ave.
Las Vegas, NV 89103
2340 E. Calvada Blvd, Suite #7.
Pahrump, NV 89048
As you begin the journey toward recovery, whether you are a patient or caregiver, it is important to select a team of professionals who aim to not only treat the condition, but the entire individual as well.
At Hope Cancer Care of Nevada, we view our patients as family. Our practice utilizes state-of-the-art cancer treatment technologies including chemo within a relaxed and inviting environment; proficient cancer care doctor’s and is administered by a staff that places the patient’s dignity and comfort at the forefront.
Caregiver support, alternative practices, chemotherapy, tranquil settings and high-end modern amenities come together to create a truly comprehensive cancer care facility at our cancer center in Las Vegas, Nevada. This is the Hope difference. Take a moment to explore the possibilities available at Hope.